Schwartz Jeffrey Lawrence's Form 4 filing
Rapid Micro Biosystems, Inc.RPID · filed Jul 21, 2021
- Accession no.
- 0000899243-21-029222
- Filed
- Jul 21, 2021, 4:40 PM ET
- Trade date
- Jul 19, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $2.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwartz Jeffrey LawrenceCIK 0001702957 | Director, 10% Owner |
| Koppel AdamCIK 0001578965 | 10% Owner |
| Bain Capital Life Sciences Fund, L.P.CIK 0001687968 | 10% Owner |
| BCIP Life Sciences Associates, LPCIK 0001702921 | 10% Owner |
| Bain Capital Life Sciences Partners, LPCIK 0001703030 | 10% Owner |
| Bain Capital Life Sciences Investors, LLCCIK 0001703031 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | Class A Common Stock | CConversionAcquired | +6,999,998 | –F1 | – | 6,999,998 | Indirect | |
| Jul 19, 2021 | Class A Common Stock | CConversionAcquired | +1,334,562 | –F1 | – | 8,334,560 | Indirect | |
| Jul 19, 2021 | Class A Common Stock | PPurchaseAcquired | +100,000 | $20.00 | +$2,000,000 | 8,434,560 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of the Issuer's Series B1 Preferred Stock and Series C1 Preferred Stock automatically converted into 0.2 of a share of the Issuer's Class A Common Stock immediately prior to the closing of the Issuer's initial public offering.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.